{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:28:06Z","timestamp":1790368086461,"version":"4.1.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Modern Rheumatology"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.3109\/s10165-010-0368-5","type":"journal-article","created":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T15:18:48Z","timestamp":1388675928000},"page":"144-149","source":"Crossref","is-referenced-by-count":8,"title":["Serodiagnosis of<i>Mycobacterium avium<\/i>-complex pulmonary disease with an enzyme immunoassay kit that detects anti-glycopeptidolipid core antigen IgA antibodies in patients with rheumatoid arthritis"],"prefix":"10.1093","volume":"21","author":[{"given":"Maiko","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Banno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaneshige","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taio","family":"Naniwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihito","family":"Hayami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuzo","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,1,2]]},"reference":[{"key":"CIT0002","first-page":"367","volume":"175","author":"Griffith DE","year":"2007","journal-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial dis-eases. Am J Respir Crit Care Med"},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMra012519","volume":"346","author":"Barker AF","year":"2002","journal-title":"N Engl J Med"},{"key":"CIT0004","first-page":"375","volume":"193","author":"Remy-Jardin M","year":"1994","journal-title":"B. Lung changes in rheumatoid arthritis: CT findings. Radiology"},{"key":"CIT0005","first-page":"941","volume":"23","author":"Akira M","year":"1999","journal-title":"Hara H. Thin-section CT findings in rheumatoid arthritis-associated lung disease: CT patterns and their courses. J Comput Assist Tomogr"},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/s10165-007-0626-3","volume":"17","author":"Koike R","year":"2007","journal-title":"Mod Rheumatol"},{"key":"CIT0008","first-page":"1556","volume":"15","author":"Winthrop KL","year":"2009","journal-title":"Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy. Emerg Infect Dis"},{"key":"CIT0009","first-page":"44","volume":"12","author":"Kitada S","year":"2005","journal-title":"Use of glycopeptidolipid core antigen for serodiagnosis of mycobacterium avium complex pulmonary dis-ease in immunocompetent patients. Clin Diagn Lab Immunol"},{"key":"CIT0010","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1086\/344277","volume":"35","author":"Kitada S","year":"2002","journal-title":"Clin Infect Dis"},{"key":"CIT0011","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1183\/09031936.00061806","volume":"29","author":"Kitada S","year":"2007","journal-title":"Eur Respir J"},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1164\/ajrccm.157.5.9710018","volume":"157","author":"Perez T","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198909283211304"},{"key":"CIT0015","first-page":"2287","volume":"46","author":"Doran MF","year":"2002","journal-title":"Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum"},{"key":"CIT0016","first-page":"25","volume":"68","author":"Salliot C","year":"2009","journal-title":"Gossec L. Risk of serious infections during rituximab abatacept and anakinra treatments for rheuma-toid arthritis: meta-analyses of randomised placebo-controlled trials. Ann Rheum Dis"},{"key":"CIT0017","first-page":"1738","volume":"46","author":"Winthrop KL","year":"2008","journal-title":"Mycobacterial and other serious infections in patients receiving anti-tumor necrosis factor and other newly approved biologic therapies: case finding through the Emerging Infections Network. Clin Infect Dis"},{"key":"CIT0018","first-page":"414","volume":"3","author":"van Ingen J","year":"2007","journal-title":"Pulmonary Mycobacterium szulgai infection and treatment in a patient receiving anti-tumor necrosis factor ther-apy. Nat Clin Pract Rheumatol"},{"key":"CIT0019","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/thx.2005.056952","volume":"62","author":"Maimon N","year":"2007","journal-title":"Thorax"},{"key":"CIT0020","first-page":"486","volume":"194","author":"Saliu OY","year":"2006","journal-title":"Wallis RS. Tumor-necrosis-factor blockers: differential effects on mycobacterial immunity. J Infect Dis"},{"key":"CIT0021","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.0105-2896.2005.00227.x","volume":"203","author":"Rosenzweig SD","year":"2005","journal-title":"Immunol Rev"},{"key":"CIT0022","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/1074-7613(95)90001-2","volume":"2","author":"Flynn JL","year":"1995","journal-title":"Immunity"},{"key":"CIT0024","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/383317","volume":"38","author":"Wallis RS","year":"2004","journal-title":"Granulomatous infectious diseases associated with tumor necro-sis factor antagonists. Clin Infect Dis"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1038\/ncprheum0336"},{"key":"CIT0026","first-page":"486","volume":"194","author":"Saliu OY","year":"2006","journal-title":"Wallis RS. Tumor-necrosis-factor blockers: differential effects on mycobacterial immunity. J Infect Dis"},{"key":"CIT0027","first-page":"1556","volume":"15","author":"Winthrop KL","year":"2009","journal-title":"Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy. Emerg Infect Dis"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1378\/chest.129.6.1653"},{"key":"CIT0029","first-page":"169","volume":"51","author":"Aspinall GO","year":"1995","journal-title":"Brennan PJ. The variable surface glycolipids of mycobacteria: structures, synthesis of epitopes, and biological properties. Adv Carbohydr Chem Biochem"},{"key":"CIT0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.bi.64.070195.000333","volume":"64","author":"Brennan PJ","year":"1995","journal-title":"Annu Rev Biochem"},{"key":"CIT0032","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00296-004-0472-y","volume":"25","author":"Bilgici A","year":"2005","journal-title":"Rheumatol Int"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/s10165-010-0368-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T05:18:15Z","timestamp":1647839895000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mr\/article\/21\/2\/144-149\/6315554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":27,"aliases":["10.1007\/s10165-010-0368-5"],"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,1,2]]},"published-print":{"date-parts":[[2011,4]]}},"alternative-id":["10.3109\/s10165-010-0368-5"],"URL":"https:\/\/doi.org\/10.3109\/s10165-010-0368-5","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}